The inotropic effect of nitric oxide is dependent on the level of beta 1-adrenergic stimulation in isolated mammalian myocardium

Show simple item record

dc.contributor.author Reading, Stacey en
dc.contributor.author Barclay, JK en
dc.date.accessioned 2017-08-16T04:06:32Z en
dc.date.issued 2002 en
dc.identifier.citation Canadian Journal of Physiology and Pharmacology 80(6):569-577 2002 en
dc.identifier.issn 0008-4212 en
dc.identifier.uri http://hdl.handle.net/2292/35137 en
dc.description.abstract We tested the hypothesis that nitric oxide has a positive inotropic effect on mammalian cardiac muscle contractility and that this effect sums with the positive inotropic effect of β1-adrenergic agonists when both are present. Feline right ventricular papillary muscles were stimulated to contract isometrically at 0.2 Hz in Krebs Henseleit bicarbonate buffer (KREBS) gassed with 95% O2 and 5% CO2 (26°C; pH 7.34). The nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP, 10 5 M), and the membrane permeable cGMP analog 8-bromoguanosine-3',5'-cyclo phosphate sodium (Br-cGMP, 10 5 M), significantly increased developed force by 13.3 ± 1.5% (n = 11) and 7.8 ± 2.8% (n = 7), respectively. SNAP, at 10-5 M, significantly increased the force developed by papillary muscle treated with 10 11 M or 10 9 M dobutamine hydrochloride (a β1-adrenergic agonist) (n = 25, 11.3 ± 2.9% and 10.0 ± 3.6%, respectively) when compared with the addition of KREBS (n = 27, 2.6 ± 0.9% and 5.5 ± 0.9%), but the increase was less than predicted by the sum of inotropic effects of SNAP and dobutamine. SNAP at 10-5 M did not change developed force in muscles treated with 10 7 M dobutamine but it significantly decreased developed force in muscles challenged with 10 5 M dobutamine (n = 18, 29.3 ± 5.0%) when compared with KREBS (n = 10, 41.5 ± 6.8%). Similarly, 10 4 M 8-bromo-adenosine cyclic 3',5'-hydrogen phosphate monosodium (a membrane permeable cAMP analog) increased developed force 14.9 ± 3.3% and the addition of 10 5 M Br-cGMP to those muscles significantly reduced developed force by 3.5% ± 1.1% (n = 7). Thus, the positive inotropic effect of NO decreased and ultimately became an attenuation as the level of β1-adrenergic stimulation increased due, at least in part, to an interaction between the cAMP and cGMP second messenger pathways.Key words: nitric oxide, β1-adrenergic, cGMP, cAMP, contractility, cardiac muscle. en
dc.publisher NRC Research Press en
dc.relation.ispartofseries Canadian Journal of Physiology and Pharmacology en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title The inotropic effect of nitric oxide is dependent on the level of beta 1-adrenergic stimulation in isolated mammalian myocardium en
dc.type Journal Article en
pubs.issue 6 en
pubs.begin-page 569 en
pubs.volume 80 en
dc.rights.holder Copyright: NRC Research Press en
dc.identifier.pmid 12117306 en
pubs.declined 2017-06-25T19:48:32.414+1200 en
pubs.end-page 577 en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Article en
pubs.elements-id 629943 en
pubs.org-id Science en
pubs.org-id Exercise Sciences en
dc.identifier.eissn 1205-7541 en
pubs.record-created-at-source-date 2017-06-14 en
pubs.dimensions-id 12117306 en


Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics